Regulation of GABAA receptor α1 protein is a sensitive indicator of benzodiazepine agonist efficacy
- 8 May 1998
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 348 (2-3) , 321-324
- https://doi.org/10.1016/s0014-2999(98)00259-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Tolerance to diazepam and changes in GABAA receptor subunit expression in rat neocortical areasNeuroscience, 1997
- Pharmacokinetic and pharmacodynamic interactions of bretazenil and diazepam with alcoholBritish Journal of Clinical Pharmacology, 1996
- Benzodiazepines on trial: a research strategy for their rehabilitationTrends in Pharmacological Sciences, 1996
- Chronic bretazenil produces tolerance to chlordiazepoxide, midazolam, and abecarnilPharmacology Biochemistry and Behavior, 1995
- Preclinical dependence liability of benzodiazepine receptor partial agonistsEuropean Neuropsychopharmacology, 1993
- Triazolam is more efficacious than diazepam in a broad spectrum of recombinant GABAA receptorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Novel anxiolytics that act as partial agonists at benzodiazepine receptorsTrends in Pharmacological Sciences, 1990
- Relationship of agonist efficacy to changes in GABA sensitivity and anticonvulsant tolerance following chronic benzodiazepine ligand exposureEuropean Journal of Pharmacology, 1989
- DEPENDENCE POTENTIAL OF BENZODIAZEPINESThe Lancet, 1988
- ‘Inverse agonists’, cooperativity and drug action at benzodiazepine receptorsTrends in Pharmacological Sciences, 1986